Delivery Order SPE2DE24DA010-SPE2D625F8YH9
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for leadless accessories with a ceiling value of $1,500. The contract, awarded on May 30, 2025, utilizes fixed-price pricing with economic price adjustment provisions and has an ultimate completion date of June 4, 2025. This delivery order represents a child contract with no set-aside designation, indicating full and open competition. The...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,000 delivery order for leadless accessories by the Medical Supply Chain division of the Department of Defense on September 12, 2025, with an ultimate completion date of September 17, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350 by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with an ultimate completion date of August 29, 2025. The contract, which was not set-aside and available through full and open competition, is for the delivery of Aveir Leadless Pacemakers to be performed at Abbott's location in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $10,500 by the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The contract, designated as AVEIR (likely referencing Abbott's Aveir Leadless Pacemaker technology), involves delivery to Santa Clara, California, with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F8YH9Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 fixed-price delivery order with economic price adjustment for leadless accessories by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract, with an ultimate completion date of July 31, 2025, represents a child award under Abbott's broader federal cardiovascular medical device portfolio. No set-aside designation was applied to this award, indicating full and open competition. The place of performance is Santa Clara, California. This delivery order supports the federal government's cardiovascular medical device procurement needs through Abbott's extensive capabilities in advanced medical technologies. Abbott Vascular has established itself as a critical supplier to federal healthcare systems, particularly through its participation in the Defense Logistics Agency's $117.1 million indefinite delivery contract for comprehensive procedural packages encompassing cardiovascular technologies, devices, instrumentation, and accessories. The leadless accessories referenced in this award align with Abbott's product portfolio of advanced cardiovascular solutions, including its Aveir Leadless Pacemakers and related medical devices that serve complex federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/28/25 |